Wells Fargo
BRLI

Wells Fargo’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Wells Fargo’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51,985
Closed -$2.15M – 6756
2015
Q2 		$2.15M Sell
51,985
-77,500
-60% -$2.78M ﹤0.01% 3048
2015
Q1 		$4.56M Sell
129,485
-10,889
-8% -$368K ﹤0.01% 2441
2014
Q4 		$4.51M Sell
140,374
-19
-0% -$550 ﹤0.01% 2422
2014
Q3 		$3.94M Buy
140,393
+6,782
+5% +$207K ﹤0.01% 2498
2014
Q2 		$4.04M Buy
133,611
+444
+0.3% +$12.3K ﹤0.01% 2486
2014
Q1 		$3.69M Buy
133,167
+2,426
+2% +$63.5K ﹤0.01% 2544
2013
Q4 		$3.34M Buy
130,741
+33,040
+34% +$1.02M ﹤0.01% 2562
2013
Q3 		$2.92M Buy
97,701
+8,126
+9% +$226K ﹤0.01% 2605
2013
Q2 		$2.58M Buy
+89,575
New +$2.47M ﹤0.01% 2620

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Wells Fargo's BRLI Position: Q3 2015 in Review

Wells Fargo sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 51,985 shares — an estimated $2.15M sold.

Wells Fargo first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $4.56M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Wells Fargo reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Wells Fargo sold 51,985 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.15M.
  • Wells Fargo first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Wells Fargo's BIO-REFERENCE LABS INC-NEW- position peaked at $4.56M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Wells Fargo's 13F filing for Q3 2015, filed 13 Nov 2015.